RELMADA THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $7.6M | $9.2M |
| FY2020 | — | $105.6M | $2.5M |
| FY2021 | — | $208.3M | $44.4M |
| FY2022 | — | $140.4M | $5.4M |
| FY2023 | — | $85.4M | $4.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $7.6M | $9.2M |
| FY2020 | — | $105.6M | $2.5M |
| FY2021 | — | $208.3M | $44.4M |
| FY2022 | — | $140.4M | $5.4M |
| FY2023 | — | $85.4M | $4.1M |